title: Progressive renal toxicity due to ifosfamide.
abstract: A prospective and follow up study of renal tubular and glomerular function in 11 children receiving ifosfamide treatment was conducted. Each child received between four and 14 courses of ifosfamide, given as a continuous infusion of 3 g/m2 over 24 hours for two or three days. Evidence of renal toxicity was seen in all patients. There was a treatment related rise in urinary tubular markers (N-acetyl-glucosaminidase and alpha 1 microglobulin). Recovery was limited, so that by the fourth course of treatment all values remained abnormal. There was an associated treatment related reduction in plasma phosphate concentration. Urinary albumin also showed a treatment related rise, but with fewer abnormal values. Electrophoresis was used to confirm tubular or glomerular patterns. Glomerular toxicity was less severe and occurred in fewer patients. The follow up study showed persistence of tubular damage in all seven patients examined, and there was evidence of glomerular damage in five of the seven children. Children receiving ifosfamide need to be carefully monitored for renal toxicity both during treatment and at follow up.
authors.affiliation: Department of Paediatrics and Child Health, St James's University Hospital, Leeds.
authors.forename: D
authors.initials: D
authors.lastname: Heney
authors.forename: J
authors.initials: J
authors.lastname: Wheeldon
authors.forename: P
authors.initials: P
authors.lastname: Rushworth
authors.forename: C
authors.initials: C
authors.lastname: Chapman
authors.forename: I J
authors.initials: IJ
authors.lastname: Lewis
authors.forename: C C
authors.initials: CC
authors.lastname: Bailey
mesh_terms: D000118:Acetylglucosaminidase / Q000652:urine; D000419:Albuminuria / Q000139:chemically induced; D000510:Alpha-Globulins / Q000652:urine; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D007674:Kidney Diseases / Q000097:blood / Q000139:chemically induced* / Q000652:urine; D007678:Kidney Glomerulus / Q000187:drug effects* / Q000503:physiopathology; D007684:Kidney Tubules / Q000187:drug effects* / Q000503:physiopathology; D008297:Male; D011446:Prospective Studies; D014168:Transferrin / Q000652:urine
chemical_list: D000510:Alpha-Globulins; D014168:Transferrin; C016001:alpha-1-microglobulin; D000118:Acetylglucosaminidase; D007069:Ifosfamide